Skip to main content

Pain treatment workshop and parenteral nutrition workshop at the South Egypt Cancer Institute

under the care of
Mr. Dr. Ahmed El-Minshawy, President of Assiut University
And Mrs. Dr. Iman Mosaad Zaki, Dean of the South Egypt Cancer Institute
A workshop for the treatment of pain and a workshop on parenteral nutrition were held on the sidelines of the conference of the Department of Maternal Medicine
45888

 

0233

 

 
 

Efficacy of Ketamine versus Magnesium Sulphate as Adjuvants to Levobupivacaine in Ultrasound Bilevel Erector Spinae Block in Breast Cancer Surgery (a Double-Blinded Randomized …

Research Authors
Fatma Adel El Sherif, Hamdy Abbas Youssef, Khaled Mohamed Fares, Sahar Abdel-Baky Mohamed, Ali Rabiee Ali, Ahmed M Thabet
Research Date
Research Journal
Local and Regional Anesthesia
Research Member
Khaled Mohamed Fares Ali
Sahar Abdel Baky Mohamed Ahmad
Research Publisher
Dove Press
Research Vol
87-96
Research Year
2022

Genetic variation in FOXP3 and ROR‑γ genes in pediatric acute lymphocytic leukemia (ALL) patients: correlation with associated cytokines

Research Abstract

Background FOXP3 and ROR-γ genes are master regulators of the Treg and Th17 diferentiation, respectively. This work was planned to investigate the impact of FOXP3 (rs3761548C/A and rs3761549C/T) and ROR-γ (rs9017A/G & rs9826A/G) gene polymorphism on the vulnerability of pediatric Egyptians to acute lymphoblastic leukemia (ALL). Furthermore, we evaluated the impact of these genetic variations on Treg/Th17-related cytokines. Methods FOXP3 SNPs were genotyped using PCR-based restriction fragment length polymorphism (PCR-RFLP), while ROR-γ SNPs polymorphism were performed by PCR-sequence-specifc primer (PCR-SSP). An Enzyme-linked immunosorbent assay (ELISA) was used to assess the levels of Treg/Th17 associated cytokines on 128 ALL children and 124 healthy donors. Results Compared to controls, patients had a signifcant increase (p<0.01/p<0.05) in FOXP3rs3761548CC genotype and a signifcant decrease (p<0.001/p<0.01) inrs3761548CA genotype. A signifcant elevation (p<0.001/p<0.01) in ROR-γ rs9017AA genotype and a signifcant reduction (p<0.01/p<0.05) in rs9017AG genotype were detected in ALL patients versus controls. An insignifcant change in FOXP3 (rs3761549C/T) and ROR-γ (rs9826A/G) genotypes was demonstrated between both groups. ROR-γ GG and GA haplotypes were signifcantly decreased (p<0.05/p<0.05; p<0.05/p<0.05) in ALL subjects compared to healthy ones. Relapsed patients had a signifcantly higher (p<0.05/P<0.05) frequency of FOXP3 rs3761548CA genotype than non-relapsed subjects. ROR-γ rs9017AG and rs9826GG genotypes might be associated with the increase in IL-23 plasma level. Conclusions Our preliminary data provided evidence for the impact ofFOXP3 (rs3761548C/A) and ROR-γ (rs9017A/G) gene polymorphisms and the occurrence of ALL in Egyptian children. Another large-scale prospective study should be conducted to validate these fndings. Keywords Pediatric ALL · FOXP3 · ROR-γ · SNPs · Cytokines · Treg/Th17 cells

Research Authors
Eman A. El‑maadawy1 · Rania M. Bakry2 · Mohamed M. Moussa3 · Sobhy Hasab El‑Naby4 · Roba M. Talaat
Research Date
Research Department
Research File
Research Journal
Discover Oncology
Research Pages
86
Research Publisher
Springer
Research Rank
4.67
Research Vol
13
Research Website
http://doi.org/10.1007/S12672-022-00549-3
Research Year
2022

Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2

Research Abstract

Abstract: Coronavirus disease 2019 (COVID-19) has affected millions of people worldwide. During the early stages of vaccination in Egypt, the ChAdOx1 nCoV-19 and BBIBP-CorV vaccines were the most distributed. The aim of this study was to compare the immune responses and short-term efficacies of these two vaccines. We recruited adults who received two doses of either vaccine. Samples were collected after the first dose of ChAdOx1 nCoV-1 and after the second dose of both vaccines. Antibodies against SARS-CoV-2 antigens were measured using LABScreen™ COVID Plus kits, and cell-mediated immune responses were assessed using flow cytometry. Of the 109 recruited subjects, 60 (55%) received the ChAdOx1 nCoV-19 vaccine, and the remainder received the BBIBPCorV vaccine. The total antibody level did not significantly differ between the two groups. The level of the anti-spike subunit 2 (S2) antibody was significantly higher in the ChAdOx1 nCoV-19 group. The percentages of both total T cells and B cells were unaffected by the type of vaccination. However, the ChAdOx1 nCoV-1 vaccine was significantly associated with a higher percentage of CD8+ cells. The vaccines did not significantly differ in the number or severity of infections postvaccination. None of the participants were admitted to the hospital or died of COVID-19 infection. In conclusion, the BBIBP-CorV vaccine is associated with an immune response and protection against infection that is comparable to that of the ChAdOx1 nCoV-1 vaccine. Follow-up is needed to study the long-term protective effects of both vaccines. Inactivated vaccines are easier to manufacture in developing countries and their limited side effects may lead to better economic benefits by limiting the number of absences from work. Keywords: COVID-19; SARS-CoV-2; Egypt; ChAdOx1 nCoV-1; BBIBP-CorV

Research Authors
Ahmed Samir Abdelhafiz 1 , Asmaa Ali 2,3, Mahmoud M. Kamel 1,* , Eman Hasan Ahmed 4 , Douaa M. Sayed 4 and Rania M. Bakry 4
Research Date
Research Department
Research File
Research Journal
Vaccines
Research Pages
1462
Research Publisher
MDPI
Research Rank
3.84
Research Vol
10
Research Website
http://www.mdpi.com/journal/vaccines
Research Year
2022

Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients

Research Authors
Israa Mostafa Kamal, Doaa F Temerik, Etemad H Yassin, Eman Mosad, Marwa T Hussien
Research Date
Research Department
Research Journal
Asian Pacific Journal of Cancer Prevention
Research Pages
4213-4225
Research Publisher
West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter
Research Year
2022

Spastic paraplegia 20 and serine/threonine protein kinase 31 expression for the detection of colorectal cancer"

Research Authors
Nivin A. Hassan
Research Date
Research Department
Research Journal
Cellular Physiology and Biochemistry
Research Member
Research Publisher
Cellular Physiology and Biochemistry
Research Year
2022

18F-FDG gallbladder uptake: observation from a total-body PET/CT scanner

Research Abstract

Background

Total-body positron emission tomography/computed tomography (PET/CT) scanners are characterized by higher signal collection efficiency and greater spatial resolution compared to conventional scanners, allowing for delayed imaging and improved image quality. These advantages may also lead to better detection of physiological processes that diagnostic imaging professionals should be aware of. The gallbladder (GB) is not usually visualized as an 18F-2-fluorodeoxyglucose (18F-FDG)-avid structure in routine clinical PET/CT studies; however, with the total-body PET/CT, we have been increasingly visualizing GB activity without it being involved in an inflammatory or neoplastic process. The aim of this study was to report visualization rates and characteristics of GB 18F-FDG uptake observed in both healthy and oncological subjects scanned on a total-body PET/CT system.

Materials and methods

Scans from 73 participants (48 healthy and 25 with newly diagnosed lymphoma) who underwent 18F-FDG total-body PET/CT were retrospectively reviewed. Subjects were scanned at multiple timepoints up to 3 h post-injection. Gallbladder 18F-FDG activity was graded using liver uptake as a reference, and the pattern was qualified as present in the wall, lumen, or both. Participants’ characteristics, such as age, sex, body-mass index, blood glucose, and other clinical parameters, were collected to assess for any significant correlation with GB 18F-FDG uptake.

Results

All 73 subjects showed GB uptake at one or more imaging timepoints. An increase in uptake intensity overtime was observed up until the 180-min scan, and the visualization rate of GB 18F-FDG uptake was 100% in the 120- and 180-min post-injection scans. GB wall uptake was detected in a significant number of patients (44/73, 60%), especially at early timepoint scans, whereas luminal activity was detected in 71/73 (97%) subjects, especially at later timepoint scans. No significant correlation was found between GB uptake intensity/pattern and subjects’ characteristics.

Conclusion

The consistent observation of GB 18F-FDG uptake recorded in this study in healthy participants and subjects with a new oncological diagnosis indicates that this is a normal physiologic finding rather than representing an exception.

 

Research Authors
Anna Calabro’, Yasser G. Abdelhafez, Elizabeth K. A. Triumbari, Benjamin A. Spencer, Moon S. Chen Jr., Domenico Albano, Christopher R. Cassim, Francesco Bertagna, Francesco Dondi, Si
Research Date
Research Journal
BMC Medical Imaging
Research Member
Research Publisher
Spinger Nature
Research Rank
Q2
Research Vol
23
Research Year
2023
Subscribe to